| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |